Business Description
Biomind Labs Inc
NAICS : 541714
SIC : 3741
ISIN : CA0907021012
Description
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -28.64 | |||||
| Debt-to-Equity | -0.58 | |||||
| Debt-to-EBITDA | -2.8 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.45 | |||||
| 9-Day RSI | 43.08 | |||||
| 14-Day RSI | 45.49 | |||||
| 6-1 Month Momentum % | -20.93 | |||||
| 12-1 Month Momentum % | 8060 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.02 | |||||
| Quick Ratio | 0.02 | |||||
| Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -3.36 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -848.13 | |||||
| ROIC % | -38.46 | |||||
| ROC (Joel Greenblatt) % | -1217.88 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -83.79 | |||||
| EV-to-EBITDA | -85.56 | |||||
| EV-to-FCF | -58.73 | |||||
| Earnings Yield (Greenblatt) % | -1.19 | |||||
| FCF Yield % | -1.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biomind Labs Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.013 | ||
| Beta | 14.18 | ||
| Volatility % | 3661.11 | ||
| 14-Day RSI | 45.49 | ||
| 14-Day ATR (€) | 0.035854 | ||
| 20-Day SMA (€) | 0.2638 | ||
| 12-1 Month Momentum % | 8060 | ||
| 52-Week Range (€) | 0.0005 - 0.725 | ||
| Shares Outstanding (Mil) | 77.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biomind Labs Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biomind Labs Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biomind Labs Inc Frequently Asked Questions
What is Biomind Labs Inc(FRA:3XI)'s stock price today?
The current price of FRA:3XI is €0.23. The 52 week high of FRA:3XI is €0.73 and 52 week low is €0.00.
When is next earnings date of Biomind Labs Inc(FRA:3XI)?
The next earnings date of Biomind Labs Inc(FRA:3XI) is .
Does Biomind Labs Inc(FRA:3XI) pay dividends? If so, how much?
Biomind Labs Inc(FRA:3XI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers